Lieke Schoenmaker

Papers

Total Citations

H-Index

About

Dr. Lieke Schoenmaker is at the forefront of precision oncology, where her work centers on advancing cancer diagnostics through genomic technologies. Her most impactful contribution is the clinical validation of whole genome sequencing (WGS) as a comprehensive, all-in-one test for cancer patients. In her landmark 2021 study, cited over 80 times, she demonstrated that WGS using fresh-frozen tissue and matched blood samples can replace the need for multiple, fragmented biomarker tests—a crucial step forward as biopsies become smaller and the demand for broader genetic profiling grows. This work not only streamlines diagnostics but also ensures that even limited tissue samples yield maximal actionable data. By championing a single, inclusive genomic test, Schoenmaker is helping to reshape clinical workflows, making comprehensive tumor profiling more accessible and efficient. Her research bridges the gap between cutting-edge genomics and routine clinical practice, positioning her as a key voice in the movement toward truly personalized cancer care. For students and researchers, her work exemplifies how rigorous validation can translate powerful technologies into real-world patient benefits.